Efficacy and Safety of Lapatinib Treatment in Trastuzumab Pretreated Patients with HER2 Positive Metastatic Breast Cancer - An Analysis of IntERB Registry in the Czech Republic

被引：0
|
作者：
Grell, P. [1 ]
Kandrnal, V. [2 ]
Bortlicek, Z. [2 ]
Vyzula, R. [1 ]
机构：
[1] Masaryk Mem Canc Inst, Brno, Czech Republic
[2] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S94 / S95
页数：2
相关论文
共 50 条
  • [21] Efficacy of trastuzumab in unselected patients with HER2-positive metastatic breast cancer: a retrospective analysis
    Collova, Elena
    Ferzi, Antonella
    Scandurra, Giuseppa
    Aurilio, Gaetano
    Torri, Valter
    Porcu, Luca
    Sano, Maria Vita
    Taibi, Eleonora
    Foglietta, Jennifer
    Generali, Daniele
    Andreis, Daniele
    Dazzani, Maria Chiara
    Bramati, Annalisa
    Marcon, Ilaria
    Atzori, Francesco
    Cinieri, Saverio
    Tondulli, Luca
    Grasso, Donatalla
    Nole, Franco
    Petrella, Maria Cristina
    Gori, Stefania
    La Verde, Nicla
    TUMORI, 2014, 100 (04) : 426 - 431
  • [22] Vinflunine in combination with trastuzumab: an active combination in the treatment of HER2 positive metastatic breast cancer
    Paridaens, R.
    Wildiers, H.
    Dalenc, F.
    Rixe, O.
    Roche, H.
    Cadic, V
    F-M, Delgado
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S70 - S70
  • [23] A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
    J. Gavilá
    J. De La Haba
    B. Bermejo
    Á. Rodríguez-Lescure
    A. Antón
    E. Ciruelos
    J. Brunet
    E. Muñoz-Couselo
    M. Santisteban
    C. A. Rodríguez Sánchez
    A. Santaballa
    P. Sánchez Rovira
    J. Á. García Sáenz
    M. Ruiz-Borrego
    A. L. Guerrero-Zotano
    M. Huerta
    A. Cotes-Sanchís
    J. Lao Romera
    E. Aguirre
    J. Cortés
    A. Llombart-Cussac
    Clinical and Translational Oncology, 2020, 22 : 420 - 428
  • [24] A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
    Gavila, J.
    De La Haba, J.
    Bermejo, B.
    Rodriguez-Lescure, A.
    Anton, A.
    Ciruelos, E.
    Brunet, J.
    Munoz-Couselo, E.
    Santisteban, M.
    Rodriguez Sanchez, C. A.
    Santaballa, A.
    Sanchez Rovira, P.
    Garcia Saenz, J. a.
    Ruiz-Borrego, M.
    Guerrero-Zotano, A. L.
    Huerta, M.
    Cotes-Sanchis, A.
    Lao Romera, J.
    Aguirre, E.
    Cortes, J.
    Llombart-Cussac, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (03): : 420 - 428
  • [25] HALT MBC: HER2 Suppression with the Addition of Lapatinib to Trastuzumab in HER2-Positive Metastatic Breast Cancer (LPT112515).
    Lin, N.
    Danso, M.
    David, A.
    Muscato, J.
    Ellis, C.
    DeSilvio, M.
    Garofalo, A.
    Nagarwala, Y.
    Winer, E.
    CANCER RESEARCH, 2011, 71
  • [26] Efficacy and safety evaluation of eribulin-trastuzumab combination therapy with heavily pretreated HER2-positive metastatic breast cancer
    Sarici, Furkan
    Altundag, Kadri
    JOURNAL OF BUON, 2020, 25 (06): : 2562 - 2569
  • [27] Dual HER2 blockage with lapatinib and trastuzumab for Japanese patients with HER2+breast cancer
    Iwata, H.
    Yamamoto, N.
    Masuda, N.
    Bando, H.
    Kuroi, K.
    Ohno, S.
    Kasai, H.
    Morita, S.
    Sakurai, T.
    Toi, M.
    BREAST, 2015, 24 : S95 - S95
  • [28] A phase III randomized study of Paclitaxel and Trastuzumab versus Paclitaxel, Trastuzumab and Lapatinib in first line treatment of HER2 positive metastatic breast cancer.
    Crown, J. P.
    Moulton, B.
    O'Donovan, N.
    CANCER RESEARCH, 2012, 72
  • [29] HALT MBC: HER2 suppression with the addition of lapatinib to trastuzumab in HER2-positive metastatic breast cancer (LPT112515)
    Lin, Nancy U.
    Danso, Michael A.
    David, Alice K.
    Muscato, Joseph J.
    Rayson, Daniel
    Houck, William A.
    Ellis, Catherine Elizabeth
    DeSilvio, Michelle
    Garofalo, Amanda
    Nagarwala, Yasir M.
    Winer, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Efficacy and safety analysis of pyrotinib in lapatinib resistant HER2-positive metastatic breast cancer: A retrospective study
    Hua, Y.
    Yang, F.
    Yang, Y.
    Bao, S.
    Sun, C.
    Yan, X.
    Zeng, T.
    Jiang, M.
    Huang, X.
    Wu, H.
    Li, J.
    Li, W.
    Yin, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1262 - S1262
12345